New England BioLabs, Inc.

108 articles about New England BioLabs, Inc.

• New England Biolabs Continues Microbial Fermentation Partnership with ABEC

  5/4/2022

  ABEC, a global provider of engineered solutions and services for biotech manufacturing, announced it is delivering multiple 40L stainless steel fermenters to New England Biolabs®, further supporting their high-density fermentation of recombinant Escherichia coli and Pichia pastoris.

• Element Biosciences Partners with New England Biolabs® to Launch New NEBNext® Ultra™ II Kits Specifically Designed for the Element AVITI™ System

  2/22/2022

  Element Biosciences, Inc. today announced a partnership with New England Biolabs (NEB®) to commercially develop and launch products to enable compatibility of the NEBNext Ultra II portfolio with the Element AVITI System.

• New England Biolabs® Introduces Updated Versions of WarmStart® LAMP Reagents

  8/24/2021

  New England Biolabs (NEB ® ) announces the release of its newest loop-mediated isothermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix

• New England Biolabs®, Inc., Announces the NEBNext® Immune Sequencing Kits (Human and Mouse) for Sequencing-based Profiling of T- and B-Cell-mediated Immune Responses

  8/19/2021

   New England Biolabs (NEB) recently launched the NEBNext Immune Sequencing Kits, available for either human or mouse samples, to nable B-cell and/or T-cell repertoire (BCR and/or TCR) analysis of infections.

• New England Biolabs® to acquire Fluorogenics Limited

  5/10/2021

  New England Biolabs, inc. (NEB®), a leading supplier of life science reagents, today announces that it has entered into an agreement to acquire Fluorogenics Limited (FGL), a lyophilization R&D service company based in the UK. Under the terms of the agreement, FGL will become a wholly-owned subsidiary of NEB.

• New England Biolabs® and Color Partner to Provide COVID-19 Testing to Biotech Workers Essential to Global Pandemic Response

  2/2/2021

  Regularly testing New England Biolabs employees helps maintain the supply of enzymes for crucial scientific research, including developing COVID-19 vaccines.

• New England Biolabs Expands its Luna® Portfolio with the SARS-CoV-2 RT-qPCR Multiplex Assay Kit

  1/12/2021

  This new research use only kit enables high throughput multiplex detection of SARS-CoV-2 nucleic acid, supports increased sample input and reduces background amplification from possible contaminating genomic DNA.

• New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

  12/1/2020

  Combination of free user-friendly web tool, to obtain custom probe sequences, and enzyme-based technology allows for efficient depletion of abundant RNAs for virtually any organism and sample type.

• New England Biolabs® broadens its Monarch® portfolio with high molecular weight (HMW) DNA extraction kits for long-read sequencing

  11/10/2020

  New additions provide genomics researchers with improved extraction methods for ultra HMW DNA, with reduced time and increased purity, from a wide variety of biological samples

• New England Biolabs Expands its Luna® Portfolio with One-Step Master Mix for Multiplex RT-qPCR

  10/1/2020

  The new Luna Probe One-Step RT-qPCR 4X Mix with UDG enables minimal sample handling, efficient performance and sensitive detection of up to five target RNA sequences, including those of low abundance for pathogen detection.   [01-October-2020]   IPSWICH, Mass. , Oct. 1, 2020 /PRNewswire/ -- New England Biolabs ® (NEB ® ) today announced the launch of its Luna Probe One-S

• New England Biolabs' SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit Enables Visual Detection of Novel Coronavirus In 30 Minutes

  7/10/2020

  New England Biolabs ® (NEB ® ) today announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the detection of novel coronavirus, SARS-CoV

• 

  Genetown Hotbed: Churning Along During the COVID-19 Pandemic

  3/31/2020

  As the biopharma industry responds to the COVID-19 pandemic, some of the area's companies are at the very frontlines of drug development against the disease, while others play supporting roles for the entire industry. Here's a look.

• New England Biolabs® to Showcase Next Generation Sequencing Sample Preparation Innovations at AGBT™ 2020

  2/21/2020

  Data will be presented on new and upcoming technologies, including a range of RNA depletion solutions, new Enzymatic Methyl-seq (EM-seq™) applications, new technologies for long-read sequencing applications and updates for RNA-seq workflows, including UMIs (Unique Molecular Indices).

• New England Biolabs® Announces the Donald G. Comb Honorary Lectureship Series in Celebration of Company Founder

  11/18/2019

  Featuring pioneers in molecular biology, inaugural lecture to take place on November 20th, 2019.

• New England Biolabs®, Inc. opens eighth subsidiary in Australia

  7/3/2019

  New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd.

• 

  Paper Outlines New Thinking and Knowledge of CRISPR and Off-Target Analysis

  6/19/2019

  When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...

• Bioz Has Partnered With NEB to Empower Life Science Researchers

  6/13/2019

  Bioz, Inc., a Silicon Valley AI data company, is proud to announce a new partnership with the world leader in the discovery and production of enzymes for molecular biology applications: New England Biolabs®.

• New England Biolabs® expands its Monarch Nucleic Acid Purification portfolio with a genomic DNA extraction and purification kit

  5/15/2019

  A comprehensive solution for cell lysis, RNA removal and purification of intact genomic DNA from a wide variety of biological samples, including, but not limited to, cultured cells, blood and mammalian tissues.

• New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for Bisulfite-Free Methylation Analysis

  4/29/2019

   New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis.

• New England Biolabs® Announces 2019 Passion in Science Awards® Recipients

  4/3/2019

   New England Biolabs, Inc. (NEB®), today announced the winners of its third Passion in Science Awards, which acknowledge scientists for their innovative work that goes above and beyond the boundaries of pure science to make a profound impact on other fields, including the arts, humanitarian service, environmental stewardship, and science mentorship.